Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “control”

270 pharma patents match "control" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 270
Index total 30,257
Page 7 / 12

Quick answer

This filtered view shows 270 pharmaceutical patents matching "control" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

270 results for “control” · 30,257 patents in full index Clear search

  1. US 8828980

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  2. US 8828429

    Release-control composition

    Takeda Pharmaceutical Company Limited · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted

  3. US 8815801

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  4. US 8796332

    Compositions and methods for controlling infections

    Regents of the University of Minnesota · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  5. US 8784870

    Controlled release compositions for modulating free-radical induced damage and methods of use thereof

    The Regents of the University of California · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8784885

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  7. US 8748569

    Peptide amphiphiles and methods to electrostatically control bioactivity of the ikvav peptide epitope

    Northwestern University · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  8. US 8735126

    Disease control with tick phospholipase A2

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

    granted

  9. US 8728488

    Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted May 20, 2014 · Expires May 15, 2034

    granted

  10. US 8722084

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted May 13, 2014 · Expires May 8, 2034

    granted

  11. US 8715591

    Microfluidic apparatus to control liposome formation

    The United States of America, as Represented by the Secretary of Commerce National Institute of Standards and Technology · Granted May 6, 2014 · Expires May 1, 2034

    granted

  12. US 8715689

    Chimeric west nile/dengue viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

    granted

  13. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  14. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  15. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  16. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  17. US 8668924

    Wound dressing and method for controlling severe, life-threatening bleeding

    Providence Health System—Oregon · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted

  18. US 8663968

    Simian T-cell lymphotropic virus

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  19. US 8658626

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted

  20. US 8648119

    Controlled release immunomodulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  21. US 8642048

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  22. US 8642561

    Peptides whose uptake by cells is controllable

    The Regents of the University of California · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  23. US 8637050

    Peptide vaccines against group A streptococci

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  24. US 8628764

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.